EdgarLookup

BROWN & BROWN, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that BROWN & BROWN, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
17.9%
Profit Margin
Net income ÷ revenue
3.5%
Return on Assets
Net income ÷ assets
0.69x
Debt-to-Equity
Total liabilities ÷ equity
+22.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.90B Feb 12, 2026
FY2025 Dec 31, 2024 $4.81B Feb 12, 2026
FY2025 Dec 31, 2023 $4.26B Feb 12, 2026
FY2024 Dec 31, 2022 $3.57B Feb 13, 2025
FY2023 Dec 31, 2021 $3.05B Feb 22, 2024
FY2020 Dec 31, 2020 $642.11M Feb 23, 2021
FY2020 Sep 30, 2020 $673.96M Feb 23, 2021
FY2020 Jun 30, 2020 $598.81M Feb 23, 2021
FY2020 Mar 31, 2020 $698.50M Feb 23, 2021
FY2020 Dec 31, 2019 $578.99M Feb 23, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.05B Feb 12, 2026
FY2025 Dec 31, 2024 $993.00M Feb 12, 2026
FY2025 Dec 31, 2023 $871.00M Feb 12, 2026
FY2024 Dec 31, 2022 $672.00M Feb 13, 2025
FY2023 Dec 31, 2021 $587.10M Feb 22, 2024
FY2020 Dec 31, 2020 $97.32M Feb 23, 2021
FY2020 Sep 30, 2020 $133.98M Feb 23, 2021
FY2020 Jun 30, 2020 $96.78M Feb 23, 2021
FY2020 Mar 31, 2020 $152.40M Feb 23, 2021
FY2020 Dec 31, 2019 $76.52M Feb 23, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.45B Feb 12, 2026
FY2025 Dec 31, 2024 $1.17B Feb 12, 2026
FY2025 Dec 31, 2023 $1.01B Feb 12, 2026
FY2024 Dec 31, 2022 $881.00M Feb 13, 2025
FY2023 Dec 31, 2021 $808.80M Feb 22, 2024
FY2022 Dec 31, 2020 $713.00M Feb 27, 2023
FY2021 Dec 31, 2019 $678.18M Feb 23, 2022
FY2020 Dec 31, 2018 $567.53M Feb 23, 2021
FY2019 Dec 31, 2017 $441.98M Feb 24, 2020
FY2013 Dec 31, 2013 $389.37M Feb 28, 2014

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $68.00M Feb 12, 2026
FY2025 Dec 31, 2024 $82.00M Feb 12, 2026
FY2025 Dec 31, 2023 $69.00M Feb 12, 2026
FY2024 Dec 31, 2022 $52.00M Feb 13, 2025
FY2023 Dec 31, 2021 $45.00M Feb 22, 2024
FY2022 Dec 31, 2020 $70.70M Feb 27, 2023
FY2021 Dec 31, 2019 $73.11M Feb 23, 2022
FY2020 Dec 31, 2018 $41.52M Feb 23, 2021
FY2019 Dec 31, 2017 $24.19M Feb 24, 2020
FY2018 Dec 31, 2016 $17.77M Feb 26, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $29.99B Feb 12, 2026
FY2025 Dec 31, 2024 $17.61B Feb 12, 2026
FY2024 Dec 31, 2023 $14.88B Feb 13, 2025
FY2023 Dec 31, 2022 $13.97B Feb 22, 2024
FY2023 Dec 31, 2021 $9.80B Feb 22, 2024
FY2022 Dec 31, 2020 $8.97B Feb 27, 2023
FY2021 Dec 31, 2019 $7.62B Feb 23, 2022
FY2019 Jan 1, 2019 $6.86B Feb 24, 2020
FY2020 Dec 31, 2018 $6.69B Feb 23, 2021
FY2019 Dec 31, 2017 $5.75B Feb 24, 2020

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2019 Jan 1, 2019 $3.86B Feb 24, 2020
FY2019 Dec 31, 2018 $3.69B Feb 24, 2020

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $5.58B Feb 22, 2024
FY2023 Dec 31, 2022 $4.61B Feb 22, 2024
FY2023 Dec 31, 2021 $4.20B Feb 22, 2024
FY2023 Dec 31, 2020 $3.75B Feb 22, 2024
FY2022 Dec 31, 2019 $3.35B Feb 27, 2023
FY2021 Dec 31, 2018 $3.00B Feb 23, 2022
FY2020 Dec 31, 2017 $2.58B Feb 23, 2021
FY2019 Dec 31, 2016 $2.36B Feb 24, 2020
FY2018 Dec 31, 2015 $2.15B Feb 26, 2019
FY2017 Dec 31, 2014 $2.11B Feb 28, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $15.09B Feb 12, 2026
FY2025 Dec 31, 2024 $7.97B Feb 12, 2026
FY2025 Dec 31, 2023 $7.34B Feb 12, 2026
FY2024 Dec 31, 2022 $6.67B Feb 13, 2025
FY2023 Dec 31, 2021 $4.74B Feb 22, 2024
FY2022 Dec 31, 2020 $4.40B Feb 27, 2023
FY2021 Dec 31, 2019 $3.75B Feb 23, 2022
FY2020 Dec 31, 2018 $3.43B Feb 23, 2021
FY2019 Dec 31, 2017 $2.72B Feb 24, 2020
FY2018 Dec 31, 2016 $2.68B Feb 26, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.99B Feb 12, 2026
FY2025 Dec 31, 2024 $6.13B Feb 12, 2026
FY2024 Dec 31, 2023 $5.29B Feb 13, 2025
FY2023 Dec 31, 2022 $4.55B Feb 22, 2024
FY2022 Dec 31, 2021 $4.00B Feb 27, 2023
FY2021 Dec 31, 2020 $3.52B Feb 23, 2022
FY2020 Dec 31, 2019 $3.14B Feb 23, 2021
FY2019 Dec 31, 2018 $2.83B Feb 24, 2020
FY2019 Jan 1, 2018 $2.57B Feb 24, 2020
FY2019 Dec 31, 2017 $2.46B Feb 24, 2020

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.08B Feb 12, 2026
FY2025 Dec 31, 2024 $675.00M Feb 12, 2026
FY2025 Dec 31, 2023 $700.00M Feb 12, 2026
FY2024 Dec 31, 2022 $650.00M Feb 13, 2025
FY2023 Dec 31, 2021 $693.20M Feb 22, 2024
FY2022 Dec 31, 2020 $656.20M Feb 27, 2023
FY2021 Dec 31, 2019 $542.17M Feb 23, 2022
FY2020 Dec 31, 2018 $438.96M Feb 23, 2021
FY2019 Dec 31, 2017 $573.38M Feb 24, 2020
FY2018 Dec 31, 2016 $515.65M Feb 26, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.61B Feb 12, 2026
FY2025 Dec 31, 2024 $3.82B Feb 12, 2026
FY2024 Dec 31, 2023 $3.80B Feb 13, 2025
FY2023 Dec 31, 2022 $3.94B Feb 22, 2024
FY2022 Dec 31, 2021 $2.02B Feb 27, 2023
FY2021 Dec 31, 2020 $2.10B Feb 23, 2022
FY2020 Dec 31, 2019 $1.56B Feb 23, 2021
FY2019 Dec 31, 2018 $1.51B Feb 24, 2020
FY2018 Dec 31, 2017 $976.14M Feb 26, 2019
FY2017 Dec 31, 2016 $1.07B Feb 28, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 12, 2026
FY2025 Dec 31, 2024 3 Feb 12, 2026
FY2025 Dec 31, 2023 3 Feb 12, 2026
FY2024 Dec 31, 2022 2 Feb 13, 2025
FY2023 Dec 31, 2021 2 Feb 22, 2024
FY2020 Dec 31, 2020 0 Feb 23, 2021
FY2020 Sep 30, 2020 0 Feb 23, 2021
FY2020 Jun 30, 2020 0 Feb 23, 2021
FY2020 Mar 31, 2020 0 Feb 23, 2021
FY2020 Dec 31, 2019 0 Feb 23, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 12, 2026
FY2025 Dec 31, 2024 3 Feb 12, 2026
FY2025 Dec 31, 2023 3 Feb 12, 2026
FY2024 Dec 31, 2022 2 Feb 13, 2025
FY2023 Dec 31, 2021 2 Feb 22, 2024
FY2020 Dec 31, 2020 0 Feb 23, 2021
FY2020 Sep 30, 2020 0 Feb 23, 2021
FY2020 Jun 30, 2020 0 Feb 23, 2021
FY2020 Mar 31, 2020 0 Feb 23, 2021
FY2020 Dec 31, 2019 0 Feb 23, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 336.00M Feb 12, 2026
FY2025 Dec 31, 2024 286.00M Feb 12, 2026
FY2024 Dec 31, 2023 285.00M Feb 13, 2025
FY2023 Dec 31, 2022 283.20M Feb 22, 2024
FY2022 Dec 31, 2021 282.50M Feb 27, 2023
FY2021 Dec 31, 2020 283.00M Feb 23, 2022
FY2020 Dec 31, 2019 281.66M Feb 23, 2021
FY2019 Dec 31, 2018 279.58M Feb 24, 2020
FY2018 Dec 31, 2017 276.21M Feb 26, 2019
FY2017 Dec 31, 2016 140.10M Feb 28, 2018